Daintain/AIF-1 plays roles in coronary heart disease via affecting the blood composition and promoting macrophage uptake and foam cell formation

Cellular Physiology and Biochemistry

Volumn 32, Issue 1, 2013, Pages 121-126

  Wang, Junhan ^a,c   Zhao, Yanying ^b   Wang, Wei ^a   Du, Zhongxia ^a   Yan, Dongjing ^a   Li, Chenhong ^d   Chen, Zhengwang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SOUTHWEST UNIVERSITY FOR NATIONALITIES   (China)

^c First People's Hospital of Jiangxia District   (China)

^d SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Atherosclerosis; Inflammatory factor daintain AIF 1; Lipoprotein (ox LDL); Oxidized low density; Scavenger receptor A (SRA); Superoxide dismutase (SOD)

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; C REACTIVE PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FOAM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTIMA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

MUS;

ANIMALS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; DNA-BINDING PROTEINS; FOAM CELLS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED BALB C; SCAVENGER RECEPTORS, CLASS A; SUPEROXIDE DISMUTASE; U937 CELLS;

EID: 84880183205     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000350130     Document Type: Article

References (22)

1. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
2. Libby P: Inflammation in atherosclerosis. Nature 2002;420:868-874.
3. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
4. Brown MS, Goldstein JL: Lowering plasma cholesterol by raising LDL receptors. N Engl J Med 1981;305:515-517.
5. Goldstein JL, Brown MS: The LDL receptor. Arterioscler Thromb Vasc Biol 2009;29:431-438.
6. Utans U, Arceci RJ, Yamashita Y, Russell ME: Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 1995; 95:2954-2962.
7. Chen ZW, Ahren B, Ostenson CG, Cintra A, Bergman T, Moller C, Fuxe K, Mutt V, Jornvall H, Efendic S: Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB rats. Proc Natl Acad Sci U S A 1997;94:13879-13884.
8. Imai Y, Kohsaka S: Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 2002;40:164-174.
9. Tanaka S, Suzuki K, Watanabe M, Matsuda A, Tone S, Koike T: Upregulation of a new microglial gene, mrf-1, in response to programmed neuronal cell death and degeneration. J Neurosci 1998;18:6358-6369.
10. Schluesener HJ, Seid K, Meyermann R: Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide II and allograft-inflammatory factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis. Acta Neuropathol 1999;97:119-126.
11. Del Galdo F, Artlett CM, Jimenez SA: The role of allograft inflammatory factor 1 in systemic sclerosis. Curr Opin Rheumatol 2006;18:588-593.
12. Fu K, Zhao YY, Tang WX, Zhong Y, Yang TB, Wang JH: Preparation and identification of monoclonal antibodies against daintain. Hybridoma (Larchmt) 2006;25:95-97.
13. Hone DM, Tacket CO, Harris AM, Kay B, Losonsky G, Levine MM: Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J Clin Invest 1992;90:412-420.
14. Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL: Regulated expression of CD36 during monocyteto-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996;87:2020-2028.
15. de Winther MP, van Dijk KW, Havekes LM, Hofker MH: Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:290-297.
16. Schunkert H, Samani NJ: Elevated C-reactive protein in atherosclerosis-chicken or egg? N Engl J Med 2008;359:1953-1955.
17. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-1565.
18. Griendling KK, FitzGerald GA: Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 2003;108:2034-2040.
19. Kondo T, Hirose M, Kageyama K: Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb 2009;16:532-538.
20. Aviram M: Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins. Antioxid Redox Signal 1999;1:585-594.
21. Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, Yla-Herttuala S: Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 1998;18:157-167.
22. Takenaka T, Takahashi K, Kobayashi T, Oshima E, Iwasaki S, Suzuki H: Oxidized low density lipoprotein (Ox-LDL) as a marker of atherosclerosis in hemodialysis (HD) patients. Clin Nephrol 2002;58:33-37.